This is a non-core endpoint: only basic statistics are computed.
Disorders of glycosaminoglycan metabolism
E4_GLYCOSAMINOGLYC
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Remove individuals based on genotype QC
17
Control definitions
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to Disorders of glycosaminoglycan metabolism based on the number of shared cases.
Broader endpoints:
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 17 | 7 | 10 |
Unadjusted prevalence (%) | 0.00 | 0.00 | 0.01 |
Mean age at first event (years) | 45.89 | 50.66 | 42.55 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_GLYCOSAMINOGLYC – Disorders of glycosaminoglycan metabolism
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Disorders of glycosaminoglycan metabolism
↥Endpoint not on priority list, no data to show.